The U.S. Food and Drug Administration (FDA) is set to approve updated COVID-19 vaccines next week, targeting the latest virus variants. These vaccines, developed by Moderna and Pfizer-BioNTech, are explicitly designed to combat the KP.2 strain and will be swiftly available at pharmacies and doctors’ offices following approval.

Why is this important?

• Current surge: The U.S. has experienced its most extensive summer COVID-19 wave in two years, with high virus levels detected nationwide.
• Vaccine timing: The new vaccines arrive as older versions become less effective against circulating strains, offering a critical update for those looking to bolster their immunity.
• Accessibility: Although the federal government no longer covers the cost of COVID-19 vaccines, they will still be available at many locations, though access may vary by insurance coverage.

What to expect

• Availability: The updated mRNA vaccines from Moderna and Pfizer-BioNTech should be in stores within days of FDA approval. A protein-based vaccine from Novavax is expected to follow shortly after.
• Who should get it: The CDC recommends that everyone six months and older receive the updated COVID-19 vaccine and annual flu shot.
• Practical advice: If you’re at higher risk or planning to travel, getting the updated vaccine could offer timely protection against severe illness.